[Canniseur: If CBD does have some anti-cancer properties and the federal government is still limiting the amount of research on it, even when CBD is sort of kind of officially legal, then … Well, enough said about that.]
A pair of new studies are reporting that cannabidiol (CBD), a non-psychoactive substance in cannabis, has anti-cancer responses in humans.
The first study found that an 81-year-old lung cancer patient who declined chemotherapy treatment had a reduced tumor size following the use of CBD oil for one month, NORML reported.
“[T]he data presented here indicate that CBD may have had a role in the striking response in a patient with histologically proven adenocarcinoma of the lung as a result of self-administration of CBD oil for a month and in the absence of any other identifiable lifestyle, drug or dietary changes,” researchers concluded. “Further work is needed both in vitro and in vivo to better evaluate the various mechanisms of action of CBD on malignant cells, and its potential application in the treatment of not only lung cancer but also other malignancies.”
The second study found that CBD in additional to a traditional anti-cancer treatment caused “significant improvement” in clinical outcomes and a lack of disease progression for two years in two 38-year-old brain cancer patients.
The study concluded, “These observations are of particular interest because the pharmacology of cannabinoids appears to be distinct from existing oncology medications and may offer a unique and possibly synergistic option for future glioma treatment”
Previous studies have also concluded that cannabis has antitumor properties.
“During the last decade, however, several studies have now shown that CB1 and CB2 receptor agonists can act as direct antitumor agents in a variety of aggressive cancers,” researchers noted. “Using animal models, CBD has been shown to inhibit the progression of many types of cancer including glioblastoma (GBM), breast, lung, prostate and colon cancer.”
Original Post: Only 420: 2 New Studies Show CBD Has Anti-Cancer Properties
[Canniseur: Short, but timely article. Seniors seem to benefit from some cannabis consumption in whatever form.]
A new study points toward cannabis’s potential for helping seniors with common health ailments such as MS, Parkinson’s disease, amyotrophic lateral sclerosis and spinal cord damage. Symptoms of these ailments can include sleep disruptions, pain and anxiety.
The study will be highlighted at the American Academy of Neurology’s 71st annual meeting, Science Daily reports, where the researchers will refer to the medicinal use of marijuana as being a safe and effective option for many of their participants.
“Our findings show that medical marijuana is well-tolerated in people age 75 and older and may improve symptoms like chronic pain and anxiety,” said study author Dr. Laszlo Mechtler of Dent Neurologic Institute. “Future research should focus on symptoms like sleepiness and balance problems, as well as efficacy and optimal dosing.”
The study concluded that 69% of the participants had some kind of symptom relief. It’s reported that 49% experienced reduced pain, 18% saw an improvement with sleep, 15% saw neuropathy improvement and 10% saw improved anxiety symptoms. 32% of the participants reduced their use of opioids.
There were varying ratios of both THC and CBD in the tinctures, vaporizers and capsules used by the participants over a 4-month period.
Original Post: Only 420: Cannabis Helps Seniors with Health Ailments, Study Finds
[Canniseur: Measuring THC in breath is a major breakthrough! It’s long been a problem in discerning a high from 30 minutes ago vs yesterday’s high. This new device might be just right the solution.]
Hound Labs, a leader in breath diagnostics, announced results of its second clinical trial in which researchers measured THC in breath.
Results from this study confirm – for the first time in a clinical trial – that THC is present in breath for two to three hours after smoking, which is the same duration as peak impairment according to government studies. The trial also concluded that detecting THC in breath for two to three hours requires the capability to measure complex molecules in breath at extraordinarily low levels – to one trillionth of a gram per liter of breath (pg/L).
“In our trials, we discovered that THC rapidly moves from blood into breath and consistently appears in breath in very low concentrations for two to three hours,” said Dr. Kara Lynch.
Hound Labs created the world’s first marijuana and alcohol breathalyzer for employer and law enforcement use. This marks the first time a handheld device has the sensitivity required to determine recent marijuana use. Existing methods for testing THC in blood, urine, and saliva do not differentiate recent marijuana use from past use because THC can remain long after impairment subsides. Breath, on the other hand, was shown in the clinical trial to contain THC only for two to three hours, which correlates with the window of peak impairment.
“In order to solve the challenge of determining recent marijuana use, we spent five years developing new technology that enables unparalleled low levels of detection in a portable device,” said Dr. Mike Lynn, co-founder and CEO, Hound Labs. “We have been testing this technology in collaboration with one of the world’s premier research universities. After years of research and development, we are excited to have validated the Hound science and technology that will advance our collective understanding of THC in breath.”
Hound Labs has partnered with several companies to begin manufacturing its breathalyzers and anticipates providing commercial versions to charter customers later this year.
Photo: Hound Labs
Original Post: Only 420: Marijuana Breathalyzer Shows THC Remains in the Breath for 2-3 Hours